$XCHC .115  News just out X-Change Corporation and

New Post Public Reply Private Reply Replies (0) Message Board
jstops

[b]$XCHC[/b] .115  News just out X-Change Corporation and Newly-Appointed Senior Medical Advisor Steven B. Hopping, M.D., F.A.C.S., Enter Discussions on Developing a High-End Skincare Product Line

DALLAS, Feb. 12, 2013 /PRNewswire via COMTEX/ -- X-Change Corp. (NASDAQ OTC: XCHC), a U.S. boutique company whose niche is hemp extract-based cosmeceutical and nutraceutical solutions through its Phytiva brand product line, is in discussions with its newly-appointed Senior Medical Advisor, Steven B. Hopping, M.D., F.A.C.S., to expand the Company's skincare offerings to include a new retail product line. Dr. Hopping has years of experience promoting and selling top quality private label skincare products under his name. The Company and Dr. Hopping are considering expanding their respective product lines to meet the increasing demand for affordable, high-end, anti-aging and therapeutic skin care treatments. With the rapidly growing awareness among women and men of all ages that quality formulations enhance skin health and appearance, the Company believes that consumers in the United States and around the world would welcome an economical and high-quality choice in the existing skincare and skin health marketplace.

Chad Johnson, Chief Operating Officer of X-Change Corp., stated, "The real potential of establishing a skincare line through collaboration between Dr. Hopping and the Company is an exciting development. Dr. Hopping's well-known expertise in the care of skin health and appearance, combined with the Company's commitment to innovations in the skincare market, are a perfect fit. We look forward to a continued dialogue with Dr. Hopping with the intention of reaching agreement on a new and innovative line of products to offer consumers nationally and internationally."

About Steven B. Hopping, M.D., F.A.C.S.

Dr. Steven B. Hopping received his specialty training at Harvard University and has been practicing cosmetic surgery for over 20 years, assisting patients across the United States and around the world. Dr. Hopping is Board Certified by three separate surgical boards: The American Board of Cosmetic Surgery, The American Board of Facial Plastic and Reconstructive Surgery, and The American Board of Otolaryngology, Head and Neck Surgery. He is also a Diplomate of the American Board of Hair Restoration. Dr. Hopping is the Medical Director of The Center for Cosmetic Surgery and of the Washington Hair Institute in Washington, DC. He also has an active practice in Dubai. Dr. Hopping is a Clinical Professor of Surgery at George Washington University and is regarded by his peers as a highly talented and innovative cosmetic surgeon. He lectures at numerous national and international conferences each year and is recognized around the world as both a leader and innovator in the cosmetic sector. Dr. Hopping has written numerous articles and been published in medical journals related to advances in cosmetic surgery, and is frequently sought out by the media as an authority in his field.

About X-Change Corp., Phytiva, and New Ventures

X-Change Corp.'s "Phytiva" is the newly-launched brand that is a hybrid of a proven, existing product line that has been well-managed and conservatively-run for over a decade with a hemp-based product line, utilizing the unique and potent benefits of the hemp plant.

X-Change Corp. is also committed to exploring additional skincare and skin health solutions in this rapidly expanding market.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Gnosis Lab's Grand Re-Opening: A New Era for Diagnostics

Updated Category News Views 260

Gnosis Lab Grand Re-Opening Celebration Gnosis, a modern diagnostic laboratory previously known as Mountain View Medical Laboratory, is excited to announce its grand re-opening at its flagship location. This event signifies a crucial transition for the lab as it seeks to blend years of reliable community service with a fresh identity and enhanced capabilities. Commitment...

Continue Reading
New Propane Contract Boosts Titan NRG (TTNN) Growth

Updated Category Stocks Views 404

Titan NRG, Inc. Announces Major Propane Contract Secured Titan NRG, Inc. (OTC: TTNN) has a big contract for the 150,000 gallons of propane supply. Given to one of its subsidiaries, this contract represents a significant turning point for the business. Under this contract, propane will be delivered over the next year to a southern Arizona reservation. Crucially in securing...

Continue Reading
Bitcoin Price Decline: Impact of DOJ and Economic Conditions

Updated Category News Views 259

Bitcoin Price Experiences a Notable Decline Bitcoin has recently faced a serious downturn, falling to around $93,925 as fears surrounding U.S. interest rate changes and potential government sales of Bitcoin emerged. This has created a concerning environment for cryptocurrency investors, highlighting the volatility of digital assets. Market Sentiment and Economic Shifts...

Continue Reading
Cogitate and One Inc Team Up to Revolutionize Payments

Updated Category News Views 169

Cogitate Partners with One Inc to Transform Digital Payments -Customers Enjoy a Seamless Experience by Unifying All Payment Flows into One Comprehensive Platform- Cogitate, a provider of cloud-native core policy, billing, and claims applications for insurers, is excited to announce its partnership with One Inc, the leading digital payments network specifically for the...

Continue Reading
Alnylam Pharmaceuticals Achieves New Stock Milestone of $287.88

Updated Category News Views 74

Alnylam Pharmaceuticals Reaches Record Stock Price Alnylam Pharmaceuticals Inc. has recently made headlines after its stock price reached a remarkable all-time high of $287.88. This surge demonstrates a substantial increase in investor confidence, bolstered by an impressive 1-year change of 71.84% in the company's stock. Known for its groundbreaking work in RNA...

Continue Reading